Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Environmental Protection Agency [EPA-HQ-OPPT-2022-0132; FRL-9411-04-OSCPP]
 AGENCY: Environmental Protection Agency (EPA).
 ACTION: Notice.
 SUMMARY: EPA is required under the Toxic Substances Control Act (TSCA), as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act, to make information publicly available and to publish information in the 
                        **Federal Register**
                         pertaining to submissions under TSCA Section 5, including notice of receipt of a Premanufacture notice (PMN), Significant New Use Notice (SNUN) or Microbial Commercial Activity Notice (MCAN), including an amended notice or test information; an exemption application (Biotech exemption); an application for a test marketing exemption (TME), both pending and/or concluded; a notice of commencement (NOC) of manufacture (including import) for new chemical substances; and a periodic status report on new chemical substances that are currently under EPA review or have recently 
                        ( print page 15238)
                        concluded review. This document covers the period from 02/01/2022 to 02/28/2022.
 DATES: Comments identified by the specific case number provided in this document must be received on or before April 18, 2022.
 ADDRESSES: Submit your comments, identified by docket identification (ID) number EPA-HQ-OPPT-2022-0132, and the specific case number for the chemical substance related to your comment, through the Federal eRulemaking Portal at 
                        *https://www.regulations.gov.*
                         Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at 
                        *https://www.epa.gov/​dockets.* Due to the public health concerns related to COVID-19, the EPA Docket Center (EPA/DC) and Reading Room is closed to visitors with limited exceptions. The staff continues to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit 
                        *https://www.epa.gov/​dockets.*
 FOR FURTHER INFORMATION CONTACT:  *For technical information contact:*
                         Jim Rahai, Project Management and Operations Division (7407M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: (202) 564-8593; email address: 
                        *rahai.jim@epa.gov.* *For general information contact:*
                         The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554-1404; email address: 
                        *TSCA-Hotline@epa.gov.*


SUPPLEMENTARY INFORMATION: I. Executive Summary What action is the Agency taking? This document provides the receipt and status reports for the period from 02/01/2022 to 02/28/2022. The Agency is providing notice of receipt of PMNs, SNUNs and MCANs (including amended notices and test information); an exemption application under 40 CFR part 725 (Biotech exemption); TMEs, both pending and/or concluded; NOCs to manufacture a new chemical substance; and a periodic status report on new chemical substances that are currently under EPA review or have recently concluded review. EPA is also providing information on its website about cases reviewed under the amended TSCA, including the section 5 PMN/SNUN/MCAN and exemption notices received, the date of receipt, the final EPA determination on the notice, and the effective date of EPA's determination for PMN/SNUN/MCAN notices on its website at: 
                    *https://www.epa.gov/​reviewing-new-chemicals-under-toxic-substances-control-act-tsca/​status-pre-manufacture-notices.*
                     This information is updated on a weekly basis. B. What is the Agency's authority for taking this action? Under the Toxic Substances Control Act (TSCA), 15 U.S.C. 2601 
                    *et seq.,*
                     a chemical substance may be either an “existing” chemical substance or a “new” chemical substance. Any chemical substance that is not on EPA's TSCA Inventory of Chemical Substances (TSCA Inventory) is classified as a “new chemical substance,” while a chemical substance that is listed on the TSCA Inventory is classified as an “existing chemical substance.” (See TSCA section 3(11).) For more information about the TSCA Inventory please go to: 
                    *https://www.epa.gov/​tsca-inventory.* Any person who intends to manufacture (including import) a new chemical substance for a non-exempt commercial purpose, or to manufacture or process a chemical substance in a non-exempt manner for a use that EPA has determined is a significant new use, is required by TSCA section 5 to provide EPA with a PMN, MCAN or SNUN, as appropriate, before initiating the activity. EPA will review the notice, make a risk determination on the chemical substance or significant new use, and take appropriate action as described in TSCA section 5(a)(3). TSCA section 5(h)(1) authorizes EPA to allow persons, upon application and under appropriate restrictions, to manufacture or process a new chemical substance, or a chemical substance subject to a significant new use rule (SNUR) issued under TSCA section 5(a)(2), for “test marketing” purposes, upon a showing that the manufacture, processing, distribution in commerce, use, and disposal of the chemical will not present an unreasonable risk of injury to health or the environment. This is referred to as a test marketing exemption, or TME. For more information about the requirements applicable to a new chemical go to: 
                    *http://www.epa.gov/​oppt/​newchems.* Under TSCA sections 5 and 8 and EPA regulations, EPA is required to publish in the 
                    **Federal Register**
                     certain information, including notice of receipt of a PMN/SNUN/MCAN (including amended notices and test information); an exemption application under 40 CFR part 725 (biotech exemption); an application for a TME, both pending and concluded; NOCs to manufacture a new chemical substance; and a periodic status report on the new chemical substances that are currently under EPA review or have recently concluded review. C. Does this action apply to me? This action provides information that is directed to the public in general. D. Does this action have any incremental economic impacts or paperwork burdens? No. E. What should I consider as I prepare my comments for EPA? 1. 
                    *Submitting confidential business information (CBI).*
                     Do not submit this information to EPA through 
                    *regulations.gov*
                     or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as CBI and then identify electronically within the disk or CD-ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. 
                    *Tips for preparing your comments.*
                     When preparing and submitting your comments, see the commenting tips at 
                    *http://www.epa.gov/​dockets/​comments.html.* I. Status Reports In the past, EPA has published individual notices reflecting the status of TSCA section 5 filings received, pending or concluded. In 1995, the Agency modified its approach and streamlined the information published in the 
                    **Federal Register**
                     after providing notice of such changes to the public and an opportunity to comment (See the 
                    **Federal Register**
                     of May 12, 1995, (60 FR 25798) (FRL-4942-7). Since the passage of the Lautenberg amendments to TSCA in 2016, public interest in information on the status of section 5 cases under EPA review and, in particular, the final determination of 
                    ( print page 15239)
                    such cases, has increased. In an effort to be responsive to the regulated community, the users of this information, and the general public, to comply with the requirements of TSCA, to conserve EPA resources and to streamline the process and make it more timely, EPA is providing information on its website about cases reviewed under the amended TSCA, including the section 5 PMN/SNUN/MCAN and exemption notices received, the date of receipt, the final EPA determination on the notice, and the effective date of EPA's determination for PMN/SNUN/MCAN notices on its website at: 
                    *https://www.epa.gov/​reviewing-new-chemicals-under-toxic-substances-control-act-tsca/​status-pre-manufacture-notices.*
                     This information is updated on a weekly basis. III. Receipt Reports For the PMN/SNUN/MCANs that have passed an initial screening by EPA during this period, Table I provides the following information (to the extent that such information is not subject to a CBI claim) on the notices screened by EPA during this period: The EPA case number assigned to the notice that indicates whether the submission is an initial submission, or an amendment, a notation of which version was received, the date the notice was received by EPA, the submitting manufacturer (
                    *i.e.,*
                     domestic producer or importer), the potential uses identified by the manufacturer in the notice, and the chemical substance identity. As used in each of the tables in this unit, (S) indicates that the information in the table is the specific information provided by the submitter, and (G) indicates that this information in the table is generic information because the specific information provided by the submitter was claimed as CBI. Submissions which are initial submissions will not have a letter following the case number. Submissions which are amendments to previous submissions will have a case number followed by the letter “A” (
                    *e.g.,*
                     P-18-1234A). The version column designates submissions in sequence as “1”, “2”, “3”, etc. Note that in some cases, an initial submission is not numbered as version 1; this is because earlier version(s) were rejected as incomplete or invalid submissions. Note also that future versions of the following tables may adjust slightly as the Agency works to automate population of the data in the tables. Table I—PMN/SNUN/MCANs Approved * From 02/01/2022 to 02/28/2022
Case No.
Version
Received 
                             date
Manufacturer
Use
Chemical substanceJ-22-0008A
3
02/15/2022
CBI
(G) Manufacture of an alcohol
(G) Modified Yeast.J-22-0011A
2
01/28/2022
CBI
(G) Ethanol production
(G) Biofuel producing Saccharomyces cerevisiae modified, genetically stable.P-16-0218A
7
02/03/2022
CBI
(G) Reactant: Spray Foam Insulation, Architectural Coating
(G) Acetoacetylated Glycerin.P-20-0124A
4
02/18/2022
CBI
(G) Additive in Household consumer products
(S) 5-octen-4-ol, 3,5-dimethyl-, (5E)-.P-20-0126A
4
02/18/2022
CBI
(G) Additive in household consumer products
(S) 4-Decenal, 5,9-dimethyl-.P-21-0011A
3
02/01/2022
CBI
(S) Crosslinking agent for inks and coatings
(G) Hexane, 1,6-diisocyanato-, homopolymer, alkyl epoxy ether- and polyethylene glycol mono-Me ether-blocked, reaction products with propylenimine.P-21-0082A
2
02/18/2022
CBI
(G) Additive in household consumer products
(S) 1-Decen-4-yne.P-21-0205A
2
02/18/2022
CBI
(G) Additive in household consumer products
(S) Benzene, [2-[(2-methyl-1-undecen-1-yl}oxy]ethyl]-.P-21-0206A
3
02/18/2022
HollyFrontier Corporation
(G) Component of gasoline
(G) Alkanes, branched and linear.P-22-0017A
2
02/01/2022
Sasol Chemicals (USA), LLC
(S) Paraffin wax substitute for candles, Alkylate for polymer esters
(S) 1-Eicosanol, manuf. of, distn., residues.P-22-0036
2
02/07/2022
Torrecid USA, LLC
(S) coloring agent, pigment for master batch
(S) chromium iron manganese oxide.P-22-0037
1
02/03/2022
Allnex USA, Inc
(S) Additol XL 186 is a specific, high efficiency additive which improves the adhesion to metal, especially under humid conditions
(G) Polyphosphoric acids, esters with heteromonocycle homopolymer.P-22-0039
2
02/25/2022
CBI
(S) Colorant for agricultural applications
(G) Poly(oxy-1,2-ethanediyl),alpha,alpha′-[[[4-(4-alkyl heteroaryl)ene]aryl]imino]di-2,1- ethanediyl]bis[omega-hydroxy-].P-22-0040
1
02/07/2022
CBI
(G) Component used in manufacture of high performance batteries
(S) Manganate(4-), hexakis(cyano-.kappa.C)-, manganese (2+) sodium, (OC-6-11)-.P-22-0041
1
02/07/2022
CBI
(G) A component used in the manufacture of batteries
(S) Ferrate (-4), hexakis(cyano-.kappa.C)-, iron(3+) manganese(2+) sodium, (OC-6-11)-.P-22-0042
1
02/09/2022
CBI
(G) Photolithography
(G) Alkanedione, [[[(substituted)aryl]thio]aryl]-, 2-(O-acetyloxime).P-22-0044
1
02/15/2022
CBI
(G) Site Limited Intermediate
(G) Silica gel, reaction products with alkyl metal salt.P-22-0045
1
02/15/2022
AkzoNobel
(G) Polymer used in the manufacture of paint
(G) Fatty acids, polymer with modified benzofuran-1,3-dione, pentaerythritol and aromatic acid anhydride.P-22-0047
2
02/25/2022
CBI
(G) Epoxy additive
(G) Alkyl substituted carbopolycyclic acids and heteromonocyclic esters.P-22-0048
2
02/24/2022
Ashland, Inc
(S) Intermediate in film
(G) halogenated dodecyl-acetylen.SN-22-0001A
2
01/28/2022
CBI
(G) Component in polishing formulation
(S) Ethanol, 2,2′,2′′-nitrilotris-, compd. with .alpha.-[2,4,6-tris(1-phenylethyl)phenyl]-.omega.-hydroxypoly(oxy-1,2-ethanediyl) phosphate.* The term `Approved' indicates that a submission has passed a quick initial screen ensuring all required information and documents have been provided with the submission prior to the start of the 90 day review period, and in no way reflects the final status of a complete submission review.
 
 
 In Table II of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the NOCs that have passed an initial screening by EPA during this period: The EPA case number assigned to the NOC including whether the submission was an initial or amended submission, the date the NOC was received by EPA, the date of commencement provided by the submitter in the NOC, a notation of the type of amendment (
                    *e.g.,*
                     amendment to generic name, specific name, technical contact information, etc.) and chemical substance identity. Table II—NOCs Approved * From 02/01/2022 to 02/28/2022
Case No.
Received date
Commencement date
If amendment, type of amendment
Chemical substanceJ-22-0001
02/22/2022
02/15/2022
N
(G) Chromosomally-modified saccharomyces cerevisiae.J-22-0002
02/22/2022
01/31/2022
N
(G) Chromosomally-modified saccharomyces cerevisiae.P-15-0694
02/24/2022
02/21/2022
N
(S) Phenol, polymer with formaldehyde, glycidyl ether, polymers with 1,3-benzenedimethanamine, reaction products with 2-[(c12-14-alkyloxy)methyl]oxirane.P-17-0198
02/22/2022
02/07/2022
N
(S) Neodymium, chloro et hydro iso-bu neodecanoate polybutadiene aluminum complexes.P-18-0170
02/23/2022
02/23/2022
N
(S) 1-propanaminium, n,n′-(oxydi-2,1-ethanediyl)bis[3-chloro-2-hydroxy-n,n-dimethyl-, dichloride.P-19-0010
01/31/2022
01/27/2022
N
(G) Hydrogenated fatty acid dimers, polymers with 1,1′-methylenebis[4-isocyanatobenzene], polypropylene glycol, polypropylene glycol ether with trimethylolpropane (3:1), and 1,3-propanediol, propylene glycol monomethacrylate-blocked.P-19-0052
02/03/2022
06/03/2020
N
(S) Poly(oxy-1,2-ethanediyl), alpha-nonyl-omega-hydroxy-, branched and linear.P-19-0158
02/15/2022
02/08/2022
N
(G) Alkenoic acid polymer with 2-ethyl-2-(hdroxymethyl)-1,3-alkyldiol, 1,1′-methylenebis(4-isocyantocarbomonocycle) and 3-methyl-1,5-aklydiol.P-21-0005
02/11/2022
01/20/2022
N
(G) Carbonmonocyclic alkene polymer with alkyl alkenoate, alkyl alkenoate, alkyl alkenoate and polyalkyldiene alkenoate.P-21-0094
02/08/2022
01/22/2022
N
(G) Silane, halogenated.P-21-0135
02/09/2022
02/06/2022
N
(G) Alkenoic acid, allyl-, (dialkylamino)alkyl ester, polymer with dialkyl-alkylene-alkanediyl)bis[carbomoncycle], alkylalkyl alkyl-alkenoate and alkanediol mono(2-alkyl-alkenoate), diazenediyl)bis[2-alkylalkanenitrile]-initiated.P-21-0186
02/09/2022
01/18/2022
N
(G) Glycerin, alkoxylated alkyl acid esters.* The term `Approved' indicates that a submission has passed a quick initial screen ensuring all required information and documents have been provided with the submission.
 In Table III of this unit, EPA provides the following information (to the extent such information is not subject to a CBI claim) on the test information that has been received during this time period: The EPA case number assigned to the test information; the date the test information was received by EPA, the type of test information submitted, and chemical substance identity. Table III—Test Information Received From 02/01/2022 to 02/28/2022
Case No.
Received date
Type of test information
Chemical substanceJ-21-0020
02/09/2022
Complete vector sequence with annotations in FASTA format
(G) Sulfolobus solfataricus-strain cb1.P-13-0021
02/23/2022
Hexafor 6240 polymer method validation of TOP assay
(G) Perfluoroacrylate polymer.P-16-0289
02/17/2022
Particle size distribution analysis
(G) Benzene dicarboxylic acid, polymer with alkane dioic acid and aliphatic diamine.P-16-0543
02/16/2022
Exposure monitoring report
(G) Halogenophosphoric acid metal salt.P-21-0176
02/23/2022
Skin Sensitization (OECD Test Guideline 406)
(G) Alkane dioic acid, bis (poly aromatic triazine) alkanoic ether phenoxy ester.
 If you are interested in information that is not included in these tables, you may contact EPA's technical information contact or general information contact as described under 
                    **FOR FURTHER INFORMATION CONTACT**
                     to access additional non-CBI information that may be available. *Authority:*15 U.S.C. 2601 
                    *et seq.* Dated: March 14, 2022. Pamela Myrick, Director, Project Management and Operations Division, Office of Pollution Prevention and Toxics.


[FR Doc. 2022-05656 Filed 3-16-22; 8:45 am] BILLING CODE 6560-50-P